The Journal of Urology
Volume 180, Issue 4 , Pages 1235-1240 , October 2008

Inflammatory Myofibroblastic Tumors of the Genitourinary Tract—Single Entity or Continuum?

  • Liang Cheng

      Affiliations

    • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
    • Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana
    • Corresponding Author InformationCorrespondence and requests for reprints: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 350 West 11th St., Clarian Pathology Laboratory Room 4010, Indianapolis, Indiana 46202 (telephone: 317-491-6442; FAX: 317-491-6419)
    • ,
  • Stephanie R. Foster

      Affiliations

    • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • Gregory T. MacLennan

      Affiliations

    • Department of Pathology, Case Western Reserve University, Cleveland, Ohio
    • ,
  • Antonio Lopez-Beltran

      Affiliations

    • Department of Pathology, Cordoba University, Cordoba, Spain
    • ,
  • Shaobo Zhang

      Affiliations

    • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • Rodolfo Montironi

      Affiliations

    • Institute of Pathological Anatomy and Histopathology, School of Medicine, Polytechnic University of the Marche Region (Ancona), United Hospitals, Ancona, Italy

Received 5 April 2008

References 

  1. Jones EC, Clement PB, Young RH. Inflammatory pseudotumor of the urinary bladder: a clinicopathological, immunohistochemical, ultrastructural, and flow cytometric study of 13 cases. Am J Surg Pathol. 1993;17:264
  2. Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol. 2006;30:1502
  3. Lott S, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L. Soft tissue tumors of the urinary bladder, part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol. 2007;38:807
  4. Lott S, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L. Soft tissue tumors of the urinary bladder: part II: malignant neoplasms. Hum Pathol. 2007;38:963
  5. Brunn H. Two interesting benign lung tumors of contradictory histopathology. J Thorac Surg. 1939;9:119
  6. Roth JA. Reactive pseudosarcomatous response in urinary bladder. Urology. 1980;16:635
  7. Proppe KH, Scully RE, Rosai J. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas (A report of eight cases). Am J Surg Pathol. 1984;8:101
  8. Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma) (Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations). Am J Clin Pathol. 1990;94:538
  9. Netto JM, Perez LM, Kelly DR, Joseph DB. Pediatric inflammatory bladder tumors: myofibroblastic and eosinophilic subtypes. J Urol. 1999;162:1424
  10. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor) (A clinicopathologic and immunohistochemical study of 84 cases). Am J Surg Pathol. 1995;19:859
  11. Weidner N. Inflammatory (myofibroblastic) pseudotumor of the bladder: a review and differential diagnosis. Adv Anat Pathol. 1995;2:362
  12. Young RH. Spindle cell lesions of the urinary bladder. Histol Histopathol. 1990;5:505
  13. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol. 1998;15:102
  14. Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15:85
  15. Sirvent N, Hawkins AL, Moeglin D, Coindre JM, Kurzenne JY, Michiels JF, et al. ALK probe rearrangement in a t(2;11:2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: toward a molecular definition of an inflammatory myofibroblastic tumor family?. Genes Chromosomes Cancer. 2001;31:85
  16. Harik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol. 2006;30:787
  17. Horn LC, Reuter S, Biesold M. Inflammatory pseudotumor of the ureter and the urinary bladder. Pathol Res Pract. 1997;193:607
  18. Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol. 1998;15:144
  19. Arber DA, Weiss LM, Chang KL. Detection of Epstein-Barr virus in inflammatory pseudotumor. Semin Diagn Pathol. 1998;15:155
  20. Gomez-Roman JJ, Ocejo-Vinyals G, Sanchez-Velasco P, Nieto EH, Leyva-Cobián F, Val-Bernal JF. Presence of human herpesvirus-8 DNA sequences and overexpression of human IL-6 and cyclin D1 in inflammatory myofibroblastic tumor (inflammatory pseudotumor). Lab Invest. 2000;80:1121
  21. Kojima M, Nakamura S, Itoh H, Suchi T, Masawa N. Inflammatory pseudotumor of the submandibular gland: report of a case presenting with autoimmune disease-like clinical manifestations. Arch Pathol Lab Med. 2001;125:1095
  22. Al-Ahmadie H, Gomez AM, Trane N, Bove KE. Giant botryoid fibroepithelial polyp of bladder with myofibroblastic stroma and cystitis cystica et glandularis. Pediatr Dev Pathol. 2003;6:179
  23. Harper L, Michel JL, Riviere JP, Alsawhi A, De Napoli-Cocci S. Inflammatory pseudotumor of the ureter. J Pediatr Surg. 2005;40:597
  24. Cespedes RD, Lynch SC, Grider DJ. Pseudosarcomatous fibromyxoid tumor of the prostate (A case report with review of the literature). Urol Int. 1996;57:249
  25. Kapusta LR, Weiss MA, Ramsay J, Lopez-Beltran A, Srigley JR. Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 2003;27:658
  26. Emerson RE, Cheng L. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review. Anal Quant Cytol Histol. 2005;27:301
  27. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569
  28. Patel AS, Murphy KM, Hawkins AL, Cohen JS, Long PP, Perlman EJ, et al. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet. 2007;176:107
  29. Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15:931
  30. Debiec-Rychter M, Marynen P, Hagemeijer A, Pauwels P. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer. 2003;38:187
  31. Gofrit ON, Pode D, Shapiro A, Zorn KC, Pizov G. Significance of inflammatory pseudotumors in patients with a history of bladder cancer. Urology. 2007;69:1064
  32. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509
  33. Hojo H, Newton WA, Hamoudi AB, Qualman SJ, Wakasa H, Suzuki S, et al. Pseudosarcomatous myofibroblastic tumor of the urinary bladder in children: a study of 11 cases with review of the literature (An Intergroup Rhabdomyosarcoma Study). Am J Surg Pathol. 1995;19:1224
  34. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum (A tumor closely simulating inflammatory pseudotumor). Am J Surg Pathol. 1991;15:1146
  35. Iczkowski KA, Shanks JH, Gadaleanu V, Cheng L, Jones EC, Neumann R, et al. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol. 2001;14:1043
  36. Freeman A, Geddes N, Munson P, Joseph J, Ramani P, Sandison A, et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol. 2004;17:765
  37. Tsuzuki T, Magi-Galluzzi C, Epstein JI. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Am J Surg Pathol. 2004;28:1609
  38. Hirsch MS, Dal Cin P, Fletcher CD. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract. Histopathology. 2006;48:569
  39. Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg K, et al. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007;20:592
  40. Spiess PE, Tuziak T, Tibbs RF, Bassett R, Tamboli P, Brown GA, et al. Pseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol. 2007;38:753

 Nothing to disclose.

 Editor's Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1578 and 1579.

PII: S0022-5347(08)01581-4

doi: 10.1016/j.juro.2008.06.049

The Journal of Urology
Volume 180, Issue 4 , Pages 1235-1240 , October 2008

Article Tools

* Image Usage & Resolution